Internal Medicine — Old Senior Academic Day Lectures (Until Sep 2023)
Pharmacological and nonpharmacological interventions for rheumatic diseases: side effects and risks of therapy
Teaching
Competencies covered in this activity
| 1. Practise medicine within their defined scope of practice and expertise | ||||||
| 1.3. Apply knowledge of the clinical and biomedical sciences relevant to Internal Medicine | ||||||
| 1.3.8. Pharmacology as it relates to pharmacokinetics, pharmacodynamics, mechanism of action, routes of delivery and elimination, and adverse effects of medications | ||||||
| 1.3.8.1. Analgesics | ||||||
| 1.3.8.2. Antimicrobials | ||||||
| 1.3.8.3. Cardiovascular medications | ||||||
| 1.3.8.4. Endocrine medications | ||||||
| 1.3.8.5. Immune modulating therapies | ||||||
| 1.3.8.6. Neuropsychiatric medications | ||||||
| 1.3.8.7. Respiratory medications | ||||||
| 1.3.8.8. Systemic therapies for cancer | ||||||
| 1.3.8.9. Drugs commonly used recreationally | ||||||
| 1.3.8.10. Supplementary and complementary medications | ||||||
| 1.4. Apply knowledge of the following systems, clinical scenarios, conditions, diseases and therapies applicable to Internal Medicine, including the manifestations, investigation, and management | ||||||
| 1.4.9. Musculoskeletal | ||||||
| 1.4.9.1. Symptoms | ||||||
| 1.4.9.1.1. Back pain | ||||||
| 1.4.9.1.2. Muscular pain | ||||||
| 1.4.9.1.3. Proximal muscle weakness | ||||||
| 1.4.9.2. Disorders | ||||||
| 1.4.9.2.1. Acute monoarthritis | ||||||
| 1.4.9.2.2. Acute and chronic polyarthritis | ||||||
| 1.4.9.2.3. Ankylosing spondylitis | ||||||
| 1.4.9.2.4. Fibromyalgia | ||||||
| 1.4.9.2.5. Gout and pseudogout | ||||||
| 1.4.9.2.6. Osteoarthritis | ||||||
| 1.4.9.2.7. Osteomyelitis | ||||||
| 1.4.9.2.8. Paget’s disease of bone | ||||||
| 1.4.9.2.9. Raynaud’s phenomenon | ||||||
| 1.4.9.2.10. Rheumatoid arthritis | ||||||
| 1.4.9.2.11. Scleroderma | ||||||
| 1.4.9.2.12. Septic arthritis | ||||||
| 1.4.9.2.13. Sero-negative arthropathies | ||||||
| 1.4.9.2.14. Sjögren’s syndrome | ||||||
| 1.4.9.2.15. Systemic lupus erythematosis | ||||||
| 1.4.9.2.16. Temporal arteritis and polymyalgia rheumatica | ||||||
| 1.4.9.2.17. Primary and secondary bone and soft tissue neoplasms | ||||||
| 3. Plan and perform procedures and therapies for the purpose of assessment and/or management | ||||||
| 3.1. Determine the most appropriate procedures or therapies | ||||||
| 3.1.1. Fluids for volume management and resuscitation | ||||||
| 3.1.2. Blood products, recombinant factors, and anticoagulants | ||||||
| 3.1.3. Medications | ||||||
| 3.1.4. Tissue procurement for diagnosis | ||||||
| 3.1.5. Interventional procedures | ||||||
| 3.1.6. Lifestyle changes | ||||||
| 3.1.7. Interventions for behaviours associated with dependence and addiction | ||||||
| 3.1.8. Physical therapies | ||||||
| 3.1.9. Nutrition | ||||||
| 3.1.10. Complementary medicine | ||||||